ERIS Lifesciences Ltd Quarterly Results

Gross Sales

771.56

702.6

722.12

738.95

715.59

Excise Duty

0

0

0

0

0

Net Sales

771.56

702.6

722.12

738.95

715.59

Other Operating Income

1.44

2.7

5.33

2.22

4.13

Other Income

3.58

8.01

4.22

4.55

1.64

Total Income

776.58

713.31

731.67

745.72

721.36

Total Expenditure

496.29

452.91

477.14

476.66

469.73

PBIDT

280.29

260.4

254.53

269.06

251.63

Interest

48.68

54.28

57.17

59.47

60.37

PBDT

231.61

206.12

197.36

209.59

191.26

Depreciation

70.51

77.25

81

80.48

75.74

Minority Interest Before NP

0

0

0

0

0

Tax

56.31

31.39

24.86

30.25

25.34

Deferred Tax

-20.31

-4.87

4.44

2.51

0.63

Reported Profit After Tax

125.1

102.35

87.06

96.35

89.55

Minority Interest After NP

7.11

8.51

3.3

4.76

6.24

Net Profit after Minority Interest

117.99

93.84

83.76

91.59

83.31

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

117.99

93.84

83.76

91.59

83.31

EPS (Unit Curr.)

8.66

6.9

6.16

6.73

6.11

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

735

0

0

Equity

13.62

13.62

13.61

13.61

13.61

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

36.32

37.06

35.24

36.41

35.16

PBDTM(%)

30.01

29.33

27.33

28.36

26.72

PATM(%)

16.21

14.56

12.05

13.03

12.51